cautioning about the use of albumin in seriously ill patients
November 1998
Experts are now cautioning about the use of albumin in seriously ill patients.
A recent review in the British Medical Journal suggests a 6% HIGHER mortality when albumin is given to patients with hypovolemia...burns...or hypoproteinemia.
This would mean one excess death per 17 treated patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive